Skip to main content
Top
Published in: BMC Primary Care 1/2014

Open Access 01-12-2014 | Research article

Prostate specific antigen testing is associated with men’s psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study

Authors: Evelyn M Flahavan, Frances J Drummond, Kathleen Bennett, Thomas I Barron, Linda Sharp

Published in: BMC Primary Care | Issue 1/2014

Login to get access

Abstract

Background

Prostate cancer incidence has risen considerably in recent years, primarily due to Prostate Specific Antigen (PSA) testing in primary care. The objective of this study was to investigate associations between PSA testing and the psychological and physical health, and healthcare utilisation of men in a population where PSA testing is widespread.

Methods

A cross-sectional study was carried out in a population-representative sample of men ≥50 years enrolled in The Irish Longitudinal Study on Ageing (TILDA). TILDA participants underwent structured interviews, health assessments and completed standardised questionnaires. Men were classified as ever/never having received a PSA test. Multivariate logistic regression (Odds Ratios (OR) and 95% Confidence Intervals (CI) was used to determine associations between PSA testing, and men’s psychological and physical health and healthcare utilisation.

Results

This analysis included 3,628 men, 68.2% of whom ever had a PSA test. In adjusted analysis, men with sub-threshold depression were significantly less likely to have had a PSA test, (OR = 0.79, 95% CI 0.64-0.97). Likelihood of having a PSA test was inversely associated with anxiety, but this was not significant (OR = 0.79, 95% CI 0.57-1.09). Frailty (OR = 0.61, 95% CI 0.31-1.05) and eligibility for free primary care (OR = 0.63, 95% CI 0.52-0.77) were also inversely associated with PSA testing. Positive associations were observed between PSA testing and more chronic illnesses (OR = 1.11, 95% CI 1.05-1.19), more primary care visits (OR = 1.03, 95% CI 1.01-1.05) and preventative health practices, including cholesterol testing and influenza vaccination (OR = 1.35, 95% CI 1.13-1.60).

Conclusions

Men’s psychological and physical health and their healthcare utilisation are associated with PSA testing in primary care. The association between poorer psychological health, in particular sub-threshold depression, and reduced likelihood of PSA testing in primary care requires further investigation. These findings may have wider implications for other cancer screening.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127: 2893-2917. 10.1002/ijc.25516.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127: 2893-2917. 10.1002/ijc.25516.CrossRefPubMed
2.
go back to reference Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, 360: 1320-1328. 10.1056/NEJMoa0810084.CrossRefPubMed Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, 360: 1320-1328. 10.1056/NEJMoa0810084.CrossRefPubMed
3.
go back to reference Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, 360: 1310-1319. 10.1056/NEJMoa0810696.CrossRefPubMedPubMedCentral Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, 360: 1310-1319. 10.1056/NEJMoa0810696.CrossRefPubMedPubMedCentral
4.
go back to reference Drummond FJ, Sharp L, Comber H: Major inter-laboratory variations in PSA testing practices: results from national surveys in Ireland in 2006 and 2007. Ir J Med Sci. 2008, 177: 317-323. 10.1007/s11845-008-0216-1.CrossRefPubMed Drummond FJ, Sharp L, Comber H: Major inter-laboratory variations in PSA testing practices: results from national surveys in Ireland in 2006 and 2007. Ir J Med Sci. 2008, 177: 317-323. 10.1007/s11845-008-0216-1.CrossRefPubMed
5.
go back to reference Drummond FJ, Barrett E, Burns R, O'Neill C, Sharp L: The number of tPSA tests continues to rise and variation in testing practices persists: a survey of laboratory services in Ireland 2008–2010. Ir J Med Sci. 2013, Epub ahead of print Drummond FJ, Barrett E, Burns R, O'Neill C, Sharp L: The number of tPSA tests continues to rise and variation in testing practices persists: a survey of laboratory services in Ireland 2008–2010. Ir J Med Sci. 2013, Epub ahead of print
6.
go back to reference Carsin AE, Drummond FJ, Black A, van Leeuwen PJ, Sharp L, Murray LJ, Connolly D, Egevad L, Boniol M, Autier P, Comber H: Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland. Cancer Causes Control. 2010, 9: 1523-31.CrossRef Carsin AE, Drummond FJ, Black A, van Leeuwen PJ, Sharp L, Murray LJ, Connolly D, Egevad L, Boniol M, Autier P, Comber H: Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland. Cancer Causes Control. 2010, 9: 1523-31.CrossRef
7.
go back to reference Gomella LG, Johannes J, Trabulsi EJ: Current prostate cancer treatments: effect on quality of life. Urology. 2009, 73 (5 Suppl): S28-35.CrossRefPubMed Gomella LG, Johannes J, Trabulsi EJ: Current prostate cancer treatments: effect on quality of life. Urology. 2009, 73 (5 Suppl): S28-35.CrossRefPubMed
8.
go back to reference Drummond FJ, Kinnear K, O’Leary E, O’Brien K, Gavin A, Sharp L: Actual and expected treatment-related side-effects predict low health related quality-of-life in prostate cancer survivors PiCTure study. Support Care Cancer. 2013, 21 (Suppl 1): S1-S301. Drummond FJ, Kinnear K, O’Leary E, O’Brien K, Gavin A, Sharp L: Actual and expected treatment-related side-effects predict low health related quality-of-life in prostate cancer survivors PiCTure study. Support Care Cancer. 2013, 21 (Suppl 1): S1-S301.
9.
go back to reference Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA, American Cancer Society Prostate Cancer Advisory Committee: American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010, 60: 70-98. 10.3322/caac.20066.CrossRefPubMed Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA, American Cancer Society Prostate Cancer Advisory Committee: American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010, 60: 70-98. 10.3322/caac.20066.CrossRefPubMed
13.
go back to reference Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI: Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev. 2004, 13: 501-10.PubMed Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI: Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev. 2004, 13: 501-10.PubMed
14.
go back to reference Vigod SN, Kurdyak PA, Stewart DE, Gnam WH, Goering PN: Depressive symptoms as a determinant of breast and cervical cancer screening in women: a population-based study in Ontario, Canada. Arch Womens Ment Health. 2011, 14: 159-68. 10.1007/s00737-011-0210-x.CrossRefPubMed Vigod SN, Kurdyak PA, Stewart DE, Gnam WH, Goering PN: Depressive symptoms as a determinant of breast and cervical cancer screening in women: a population-based study in Ontario, Canada. Arch Womens Ment Health. 2011, 14: 159-68. 10.1007/s00737-011-0210-x.CrossRefPubMed
15.
go back to reference Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR: Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010, 48: 934-9. 10.1097/MLR.0b013e3181e57901.CrossRefPubMed Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR: Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010, 48: 934-9. 10.1097/MLR.0b013e3181e57901.CrossRefPubMed
16.
go back to reference Dale W, Bilir P, Han M, Meltzer D: The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer. 2005, 104: 467-78. 10.1002/cncr.21198.CrossRefPubMedPubMedCentral Dale W, Bilir P, Han M, Meltzer D: The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer. 2005, 104: 467-78. 10.1002/cncr.21198.CrossRefPubMedPubMedCentral
17.
go back to reference Eisen SA, Waterman B, Skinner CS, Scherrer JF, Romeis JC, Bucholz K, Heath A, Goldberg J, Lyons MJ, Tsuang MT, True WR: Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology. 1999, 53: 516-22. 10.1016/S0090-4295(98)00545-7.CrossRefPubMed Eisen SA, Waterman B, Skinner CS, Scherrer JF, Romeis JC, Bucholz K, Heath A, Goldberg J, Lyons MJ, Tsuang MT, True WR: Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology. 1999, 53: 516-22. 10.1016/S0090-4295(98)00545-7.CrossRefPubMed
18.
go back to reference Consedine NS, Adjei BA, Ramirez PM, McKiernan JM: An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1631-9. 10.1158/1055-9965.EPI-07-2538.CrossRefPubMed Consedine NS, Adjei BA, Ramirez PM, McKiernan JM: An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1631-9. 10.1158/1055-9965.EPI-07-2538.CrossRefPubMed
19.
go back to reference Kotwal AA, Schumm P, Mohile SG, Dale W: The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample. Medical care. 2012, 50: 1037-44. 10.1097/MLR.0b013e318269e096.CrossRefPubMedPubMedCentral Kotwal AA, Schumm P, Mohile SG, Dale W: The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample. Medical care. 2012, 50: 1037-44. 10.1097/MLR.0b013e318269e096.CrossRefPubMedPubMedCentral
20.
go back to reference Ross LE, Taylor YJ, Howard DL: Trends in prostate-specific antigen test use, 2000–2005. Public health Rep. 2011, 126: 228-239.PubMedPubMedCentral Ross LE, Taylor YJ, Howard DL: Trends in prostate-specific antigen test use, 2000–2005. Public health Rep. 2011, 126: 228-239.PubMedPubMedCentral
21.
go back to reference Health Services Executive: Medical Card Information. 2012, Dublin: Health Services Executive Health Services Executive: Medical Card Information. 2012, Dublin: Health Services Executive
23.
go back to reference Nolan A, Nolan B: Eligibility for free GP care, "need" and GP visiting in Ireland. Eur J Health Econ. 2008, 9: 157-63. 10.1007/s10198-007-0054-5.CrossRefPubMed Nolan A, Nolan B: Eligibility for free GP care, "need" and GP visiting in Ireland. Eur J Health Econ. 2008, 9: 157-63. 10.1007/s10198-007-0054-5.CrossRefPubMed
24.
go back to reference Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977, 1: 385-401. 10.1177/014662167700100306.CrossRef Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977, 1: 385-401. 10.1177/014662167700100306.CrossRef
25.
go back to reference Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta psychiatrica Scandinavica. 1983, 67: 361-70. 10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta psychiatrica Scandinavica. 1983, 67: 361-70. 10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed
26.
go back to reference Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-98. 10.1016/0022-3956(75)90026-6.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-98. 10.1016/0022-3956(75)90026-6.CrossRefPubMed
27.
go back to reference Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH: Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007, 166: 348-54. 10.1093/aje/kwm070.CrossRefPubMed Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH: Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007, 166: 348-54. 10.1093/aje/kwm070.CrossRefPubMed
28.
go back to reference Fleming ST, McDavid K, Pearce K, Pavlov D: Comorbidities and the risk of late-stage prostate cancer. ScientificWorldJournal. 2006, 6: 2460-70.CrossRefPubMed Fleming ST, McDavid K, Pearce K, Pavlov D: Comorbidities and the risk of late-stage prostate cancer. ScientificWorldJournal. 2006, 6: 2460-70.CrossRefPubMed
29.
go back to reference Smith SM, Ferede A, O'Dowd T: Multimorbidity in younger deprived patients: an exploratory study of research and service implications in general practice. BMC family practice. 2008, 9: 6-10.1186/1471-2296-9-6.CrossRefPubMedPubMedCentral Smith SM, Ferede A, O'Dowd T: Multimorbidity in younger deprived patients: an exploratory study of research and service implications in general practice. BMC family practice. 2008, 9: 6-10.1186/1471-2296-9-6.CrossRefPubMedPubMedCentral
30.
go back to reference Fowke JH, Signorello LB, Underwood W, Ukoli FA, Blot WJ: Obesity and prostate cancer screening among African-American and Caucasian men. Prostate. 2006, 66: 1371-80. 10.1002/pros.20377.CrossRefPubMed Fowke JH, Signorello LB, Underwood W, Ukoli FA, Blot WJ: Obesity and prostate cancer screening among African-American and Caucasian men. Prostate. 2006, 66: 1371-80. 10.1002/pros.20377.CrossRefPubMed
31.
go back to reference Torta RG, Munari J: Psychological aspects of PSA testing. Nat Rev Urol. 2009, 6: 513-5. 10.1038/nrurol.2009.146.CrossRefPubMed Torta RG, Munari J: Psychological aspects of PSA testing. Nat Rev Urol. 2009, 6: 513-5. 10.1038/nrurol.2009.146.CrossRefPubMed
32.
go back to reference Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR: Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010, 48: 934-9. 10.1097/MLR.0b013e3181e57901.CrossRefPubMed Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR: Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010, 48: 934-9. 10.1097/MLR.0b013e3181e57901.CrossRefPubMed
33.
go back to reference Burns R, Walsh B, Sharp L, O'Neill C: Prostate cancer screening practices in the Republic of Ireland: the determinants of uptake. J Health Serv Res Pol. 2012, 17: 206-11. 10.1258/jhsrp.2012.011105.CrossRef Burns R, Walsh B, Sharp L, O'Neill C: Prostate cancer screening practices in the Republic of Ireland: the determinants of uptake. J Health Serv Res Pol. 2012, 17: 206-11. 10.1258/jhsrp.2012.011105.CrossRef
35.
go back to reference Rolison JJ, Hanoch Y, Miron-Shatz T: Smokers: at risk for prostate cancer but unlikely to screen. Addictive behaviors. 2012, 37: 736-8. 10.1016/j.addbeh.2012.02.006.CrossRefPubMed Rolison JJ, Hanoch Y, Miron-Shatz T: Smokers: at risk for prostate cancer but unlikely to screen. Addictive behaviors. 2012, 37: 736-8. 10.1016/j.addbeh.2012.02.006.CrossRefPubMed
36.
go back to reference Butler CC, Pill R, Stott NC: Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion. BMJ. 1998, 316: 1878-81. 10.1136/bmj.316.7148.1878.CrossRefPubMedPubMedCentral Butler CC, Pill R, Stott NC: Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion. BMJ. 1998, 316: 1878-81. 10.1136/bmj.316.7148.1878.CrossRefPubMedPubMedCentral
37.
go back to reference Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 748-57. 10.1158/1055-9965.EPI-07-2629.CrossRefPubMed Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 748-57. 10.1158/1055-9965.EPI-07-2629.CrossRefPubMed
38.
go back to reference Drummond FJ, Carsin AE, Sharp L, Comber H: Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines. Ir J Med Sci. 2010, 179: 43-9. 10.1007/s11845-009-0376-7.CrossRefPubMed Drummond FJ, Carsin AE, Sharp L, Comber H: Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines. Ir J Med Sci. 2010, 179: 43-9. 10.1007/s11845-009-0376-7.CrossRefPubMed
39.
go back to reference Sharpley CF, Bitsika V, Christie DH: Psychological Distress among Prostate Cancer Patients: Fact Or Fiction?. Clin Med Oncol. 2008, 2: 563-72.PubMedPubMedCentral Sharpley CF, Bitsika V, Christie DH: Psychological Distress among Prostate Cancer Patients: Fact Or Fiction?. Clin Med Oncol. 2008, 2: 563-72.PubMedPubMedCentral
40.
go back to reference Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, Lewith G: Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014, 4 (3): e003901-10.1136/bmjopen-2013-003901.CrossRefPubMedPubMedCentral Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, Lewith G: Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014, 4 (3): e003901-10.1136/bmjopen-2013-003901.CrossRefPubMedPubMedCentral
41.
go back to reference Block S, Love A, Macvean M, Duchesne G, Cooper J, Kissane D: Psychological adjustment of men with prostate cancer: A review of the literature. Biopsychosocial Med. 2007, 10: 1-2. Block S, Love A, Macvean M, Duchesne G, Cooper J, Kissane D: Psychological adjustment of men with prostate cancer: A review of the literature. Biopsychosocial Med. 2007, 10: 1-2.
Metadata
Title
Prostate specific antigen testing is associated with men’s psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study
Authors
Evelyn M Flahavan
Frances J Drummond
Kathleen Bennett
Thomas I Barron
Linda Sharp
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2014
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/1471-2296-15-121

Other articles of this Issue 1/2014

BMC Primary Care 1/2014 Go to the issue